Dostarlimab-gxly

Mismatch Repair Deficient (dMMR)

Molecular Name: Dostarlimab-gxly
Active Ingredient: Dostarlimab-gxly
Strength: 50 mg/mL
Manufacturer Name:

List of Excipients: L-histidine, L-histidine hydrochloride monohydrate, polysorbate 80, trehalose dihydrate.

website background
Doctor

Why is Kineret injection prescribed?

The prescription medicine KINERET (anakinra), commonly known as an interleukin-1 receptor antagonist (IL-1Ra), is only available to adults over the age of 18 to:

To administer Kineret, a subcutaneous injection is used.

Kineret is provided in a graduated prefilled syringe and is ready for use. Using the graduated prefilled syringe, doses between 20 and 100 mg are possible. The syringe is inappropriate for pediatric patients with a body weight below 10 kg because the minimum dose is 20 mg.

Who should not take KINERET?

If you’re unsure, speak with your doctor.

What are the possible side effects of KINERET?

Severe possible side effects of KINERET include:

What documents are required to import KINERET to Dubai?

Individual Patients or hospitals may import Kineret 100 mg at a reasonable price
The following paperwork is necessary to import:

Special Precautions For Kineret

Dostarlimab-gxly is a cancer medicine used for treating certain types of endometrial cancer (cancer of the womb) that are advanced or have come back and have got worse despite treatment involving a platinum-based cancer medicine. Dostarlimab-gxly works by blocking a protein called PD-1 on certain immune cells called T cells. This helps the immune system to attack cancer cells. It is administered through intravenous injection.

Special Storage Precautions: Store in the refrigerator between 2°C to 8°C (36°F to 46°F). Do not freeze.

Key Features:

  • Dostarlimab-gxly is a cancer medicine used for treating certain types of endometrial cancer (cancer of the womb) that are advanced or have come back and have got worse despite treatment involving a platinum-based cancer medicine.
  • Dostarlimab-gxly works by blocking a protein called PD-1 on certain immune cells called T cells. This helps the immune system to attack cancer cells.
  • It is administered through intravenous injection.

About Us

We are a leading pharmaceutical wholesaler, Hayat Alhikmah, situated in Dubai. By providing generic medications, reference listed drugs, name patient import services, and temperature-controlled products simple to access for our consumers, we help them overcome geographic distances.


We offer affordable access to anakinra injection in Dubai with ease and speed. Depending on the customer’s needs, we provide a quality guarantee and shipping anywhere in the world.

Please schedule a consultation with us by calling us at +971 54 777 1238  or email us at [email protected] to know how much anakinra injection costs in Dubai. Our helpful team would be happy to assist you and provide any general or medical information.

0 +

Distributors

0 +

Ware House

0 +

Awards

FAQ's

  • You should not use dostarlimab-gxly if you are allergic to it.
  • Store in the refrigerator between 2°C to 8°C (36°F to 46°F). Do not freeze.

Dostarlimab-gxly has demonstrated considerable efficacy in the treatment of a specific form of endometrial cancer known as mismatch repair deficient (dMMR) or microsatellite instability-high (MSI-H) endometrial cancer. Clinical trials and research have consistently indicated that Dostarlimab-gxly can be a valuable therapeutic option for individuals diagnosed with this particular type of endometrial cancer, potentially resulting in favorable patient outcomes.

It is crucial to emphasize that the effectiveness of Dostarlimab-gxly may vary from one patient to another. The decision to use Dostarlimab-gxly should always be made in consultation with a qualified healthcare provider who will consider an individual’s unique medical history and treatment plan. For personalized guidance regarding the suitability of Dostarlimab-gxly for a specific condition, it is advisable to consult a healthcare professional.

  • Dostarlimab-gxly is administered through intravenous injection.
  • The recommended dose is 500 mg every three weeks.
  • Dostarlimab-gxly is effective in treating certain types of endometrial cancer (cancer of the womb) that are advanced or have come back and have got worse despite treatment involving a platinum-based cancer medicine. It is also used to treat dMMR solid tumors.
  • Common side effects may include fatigue, nausea, diarrhea, or rash.
  • Serious side effects may include immune-mediated adverse reactions or infusion-related reactions.